miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer
General physiology and biophysics · 2025
DOI: 10.4149/gpb_2024047 ↗Kurz gefasst
Fachartikel in der Zeitschrift General physiology and biophysics, 2025. Verfasst von Jiayun Ge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: MicroRNAs, Deoxycytidine, Pancreatic Neoplasms, Drug Resistance, Neoplasm.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Division of Liver Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
ORCID-Profile: Xin Wang
Zitieren
APA
Ge, J., Zhang, Z., Shao, G., Wei, D., Tang, B., Shi, Z., Zou, R., & Wang, X. (2025). miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. General physiology and biophysics. https://doi.org/10.4149/gpb_2024047
Vancouver
Ge J, Zhang Z, Shao G, Wei D, Tang B, Shi Z, et al. miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. General physiology and biophysics. 2025. doi:10.4149/gpb_2024047
BibTeX
@article{Ge2025,
author = {Ge, Jiayun and Zhang, Zhihong and Shao, Guohui and Wei, Dong and Tang, Bo and Shi, Zhitian and Zou, Renchao and Wang, Xin},
title = {miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer},
journal = {General physiology and biophysics},
year = {2025},
doi = {10.4149/gpb_2024047}
}
EUVIMED